Surgery or Stereotactic Body Radiotherapy for Early-stage Lung Cancer: What Is the Current Evidence?-Reference-Cited by-同舟云学术

Surgery or Stereotactic Body Radiotherapy for Early-stage Lung Cancer: What Is the Current Evidence?

Published:2020-01 Issue:1 Volume:21 Page:e33-e34
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Deng Han-Yu,Peng Lei

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference8 articles.

1. Stereotactic ablative radiotherapy as an alternative to lobectomy in patients with medically operable stage I NSCLC: a retrospective, multicenter analysis;Scotti;Clin Lung Cancer,2019

2. Surgery or radiotherapy for stage I lung cancer? An intention to treat analysis;Spencer;Eur Respir J,2019

3. Advanced statistics: the propensity score—a method for estimating treatment effect in observational research;Newgard;Acad Emerg Med,2004

4. Radiotherapy, lobectomy or sublobar resection? A meta-analysis of the choices for treating stage I non-small-cell lung cancer;Deng;Eur J Cardiothorac Surg,2017

5. Stereotactic ablative radiation therapy versus surgery in early lung cancer: a meta-analysis of propensity score studies;Chen;Int J Radiat Oncol Biol Phys,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 18F-FDG PET/CT radiomics for prediction of lymphovascular invasion in patients with early stage non-small cell lung cancer;Frontiers in Oncology;2023-07-21

2. Surgery should still remain the prior option for treating operable early-stage non-small-cell lung cancer;European Journal of Cardio-Thoracic Surgery;2022-05-28

3. ATM gene polymorphisms are associated with poor prognosis of non-small cell lung cancer receiving radiation therapy;Aging;2020-04-24